3B BLACKBIO DX LTD. Intrinsic Value
3BBLACKBIO · Healthcare · Current price ₹1,521.2
Is 3B BLACKBIO DX LTD. undervalued?
DocStoX estimates the fair value of 3B BLACKBIO DX LTD. at ₹1,598 per share, versus the current market price of ₹1,521. That puts the stock about +5.1% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹421), Relative P/E (₹4,417), Graham floor (₹762). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹421 (bear) to ₹1,598 (base) to ₹4,417 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,521 versus an intrinsic value of ₹1,598, 3B BLACKBIO DX LTD. currently offers +5.1% of margin.
More on 3B BLACKBIO DX LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.